These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1185394)

  • 1. Growth hormone excess and sexual precocity in polyostotic fibrous dysplasia (McCune-Albright syndrome): evidence for abnormal hypothalamic function.
    Lightner ES; Penny R; Frasier SD
    J Pediatr; 1975 Dec; 87(6 Pt 1):922-7. PubMed ID: 1185394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
    Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
    N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancy.
    Danon M; Robboy SJ; Kim S; Scully R; Crawford JD
    J Pediatr; 1975 Dec; 87(6 Pt 1):917-21. PubMed ID: 171361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian function in girls with McCune-Albright syndrome.
    Foster CM; Feuillan P; Padmanabhan V; Pescovitz OH; Beitins IZ; Comite F; Shawker TH; Loriaux DL; Cutler GB
    Pediatr Res; 1986 Sep; 20(9):859-63. PubMed ID: 3092175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome.
    Foster CM; Ross JL; Shawker T; Pescovitz OH; Loriaux DL; Cutler GB; Comite F
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1161-5. PubMed ID: 6427261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The McCune-Albright syndrome.
    Mauras N; Blizzard RM
    Acta Endocrinol Suppl (Copenh); 1986; 279():207-17. PubMed ID: 3465162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomous ovarian hyperfunction followed by gonadotrophin-dependent puberty in McCune-Albright syndrome.
    Kaufman FR; Costin G; Reid BS
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):239-42. PubMed ID: 3085997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
    Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?
    Hannon TS; Noonan K; Steinmetz R; Eugster EA; Levine MA; Pescovitz OH
    J Pediatr; 2003 May; 142(5):532-8. PubMed ID: 12756386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Evidence of hypothalamic dysfunction.
    Chung KF; Alaghband-Zadeh J; Guz A
    Am J Dis Child; 1983 Feb; 137(2):134-6. PubMed ID: 6401383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Albright syndrome associated with acromegaly: report of a case and review of the literature.
    Lipson A; Hsu TH
    Johns Hopkins Med J; 1981 Jul; 149(1):10-4. PubMed ID: 7019531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. McCune-Albright syndrome: evidence for autonomous multiendocrine hyperfunction.
    D'Armiento M; Reda G; Camagna A; Tardella L
    J Pediatr; 1983 Apr; 102(4):584-6. PubMed ID: 6403689
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.
    Feuillan PP; Jones J; Cutler GB
    J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyproterone acetate, LHRH agonist and ovarian surgery in McCune-Albright syndrome with precocious puberty and galactorrhea.
    Carani C; Pacchioni C; Baldini A; Zini D
    J Endocrinol Invest; 1988 Jun; 11(6):419-23. PubMed ID: 2974851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gigantism associated with McCune-Albright's syndrome.
    Nakagawa H; Nagasaka A; Sugiura T; Nakagawa K; Yabe Y; Nihei N; Hirooka M; Itoh M; Nakai A; Ohyama T
    Horm Metab Res; 1985 Oct; 17(10):522-7. PubMed ID: 3934058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
    Pescovitz OH; Comite F; Hench K; Barnes K; McNemar A; Foster C; Kenigsberg D; Loriaux DL; Cutler GB
    J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic hypothalamic hypogonadotropic hypogonadism with polyostotic fibrous dysplasia.
    Shires R; Whyte MP; Avioli LV
    Arch Intern Med; 1979 Oct; 139(10):1187-9. PubMed ID: 485758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. A histologic, immunocytologic and ultrastructural study of the surgically-removed adenohypophysis.
    Kovacs K; Horvath E; Thorner MO; Rogol AD
    Virchows Arch A Pathol Anat Histopathol; 1984; 403(1):77-86. PubMed ID: 6426154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome.
    Comite F; Shawker TH; Pescovitz OH; Loriaux DL; Cutler GB
    N Engl J Med; 1984 Oct; 311(16):1032-6. PubMed ID: 6434946
    [No Abstract]   [Full Text] [Related]  

  • 20. Acromegaly and hyperthyroidism associated with McCune-Albright syndrome.
    Misaki M; Shima T; Ikoma J; Morioka K; Suzuki S
    Horm Res; 1988; 30(1):26-7. PubMed ID: 3220461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.